SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-477766"
 

Search: onr:"swepub:oai:DiVA.org:uu-477766" > HLA-DQ heterodimers...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Petersdorf, Effie W.Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.;Univ Washington, Dept Med, Seattle, WA USA. (author)

HLA-DQ heterodimers in hematopoietic cell transplantation

  • Article/chapterEnglish2022

Publisher, publication year, extent ...

  • American Society of Hematology,2022
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-477766
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-477766URI
  • https://doi.org/10.1182/blood.2022015860DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • HLA-DQ heterodimers increase the susceptibility to autoimmune diseases, but their role in hematopoietic cell transplantation is unknown. We tested the hypothesis that outcome after HLA-matched and HLA-DQ-mismatched hematopoietic cell transplantation is influenced by HLA-DQ heterodimers. Heterodimers were defined in 5164 HLA-matched and 520 HLA-DQ-mismatched patients and their transplant donors according to well-established crystallographic criteria. Group 1 (G1) heterodimers are any DQA1*02/03/04/05/06a paired with any DQB1*02/03/040. Group 2 (G2) heterodimers are DQA1*01a paired with any DQB1*05/060. Multivariable models identified significantly higher relapse risk in G1G2 and G2G2 compared with G1G1 HLA-matched patients with malignant disease; risk increased with an increasing number of G2 molecules. In HLA-DQ-mismatched transplantation for malignant diseases, matching or mismatching for G2 increased relapse risk. G2 lowered disease-free survival after both HLA-matched and HLA-DQ-mismatched transplantation. A paradigm based on HLA-DQ heterodimers provides a functional definition of the hematopoietic cell transplantation barrier and a means to lower risks for future patients.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Bengtsson, MatsUppsala universitet,Klinisk immunologi(Swepub:uu)matsbs (author)
  • Horowitz, MaryCtr Int Blood & Marrow Transplant Res, Milwaukee, WI USA.;Med Coll Wisconsin, Div Hematol & Oncol, Milwaukee, WI 53226 USA. (author)
  • McKallor, CarolineFred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA. (author)
  • Spellman, Stephen R.Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA. (author)
  • Spierings, EricMatchis Fdn, Leiden, Netherlands.;Univ Med Ctr Utrecht, Utrecht, Netherlands. (author)
  • Gooley, Ted A.Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA. (author)
  • Stevenson, PhilFred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA. (author)
  • Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.;Univ Washington, Dept Med, Seattle, WA USA.Klinisk immunologi (creator_code:org_t)

Related titles

  • In:Blood: American Society of Hematology139:20, s. 3009-30170006-49711528-0020

Internet link

Find in a library

  • Blood (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view